Which statement best reflects LAST risk management?

Which statement best reflects LAST risk management?

• A. Incremental dosing, aspiration, test dosing, ultrasound guidance, and careful monitoring
• B. Large bolus dosing without monitoring
• C. Avoid aspiration
• D. No ultrasound

Answer: (A)

Preventing local anesthetic systemic toxicity hinges on minimizing how quickly and how much local anesthetic enters the bloodstream, while keeping a sharp eye on the patient for early warning signs. The best risk management approach uses multiple safeguards together: administer the drug in small, incremental amounts rather than a single large dose; perform aspiration before each injection to check that the needle isn’t in a blood vessel; use a test dose to reveal intravascular uptake before delivering the full amount; employ ultrasound guidance to visualize the needle tip and the spread of the anesthetic to avoid vessels; and monitor the patient carefully throughout and after the injection to detect any early signs of toxicity and respond promptly. Each element reduces the chance of high peak plasma levels and speeds recognition and treatment if toxicity begins. The other options weaken safety: giving a large bolus without monitoring can cause a sudden toxic surge; avoiding aspiration removes a practical check against intravascular injection; and not using ultrasound misses a valuable tool for ensuring precise, safe placement.

Preventing local anesthetic systemic toxicity hinges on minimizing how quickly and how much local anesthetic enters the bloodstream, while keeping a sharp eye on the patient for early warning signs. The best risk management approach uses multiple safeguards together: administer the drug in small, incremental amounts rather than a single large dose; perform aspiration before each injection to check that the needle isn’t in a blood vessel; use a test dose to reveal intravascular uptake before delivering the full amount; employ ultrasound guidance to visualize the needle tip and the spread of the anesthetic to avoid vessels; and monitor the patient carefully throughout and after the injection to detect any early signs of toxicity and respond promptly. Each element reduces the chance of high peak plasma levels and speeds recognition and treatment if toxicity begins.

The other options weaken safety: giving a large bolus without monitoring can cause a sudden toxic surge; avoiding aspiration removes a practical check against intravascular injection; and not using ultrasound misses a valuable tool for ensuring precise, safe placement.